Lung Non-Small Cell Carcinoma
A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.
Exact Synonyms
Lung Non-Small Cell Carcinoma
Non Small Cell Lung Cancer NOS
Non-Small Cell Cancer of Lung
Non-Small Cell Cancer of the Lung
Non-Small Cell Carcinoma of Lung
Non-Small Cell Carcinoma of the Lung
Non-small cell lung cancer, NOS
Non-Small Cell Lung Cancer
non-small cell lung cancer
Non-Small Cell Lung Carcinoma
NSCLC - Non-Small Cell Lung Cancer
NSCLC
class Information
ALT_DEFINITION
A group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Non-small cell lung cancer is the most common kind of lung cancer.
code
C2926
Contributing_Source
- Cellosaurus
- CPTAC
- CTEP
- CTRP
Display_Name
Non-Small Cell Lung Carcinoma
in_subset
- CTRP Portfolio Management Subtype Terminology
- CPTAC Terminology
- CTS-API Disease Main Type Terminology
- CTRP Disease Terminology
- CPTAC Neoplasms Codelist
- Cellosaurus Terminology
- Cellosaurus Disease Terminology
- NCIt Neoplasm Core Terminology
- CPTAC Codelists Terminology
- CTRP Terminology
- NCI CTEP Simplified Disease Classification Terminology
- oncotree_slim
- NCI CTEP SDC Non-Small Cell Lung Cancer Sub-Category Terminology
- Clinical Trials Search-Application Programming Interface Disease Category Terminology
Legacy Concept Name
Non-Small_Cell_Lung_Carcinoma
Neoplasm_Has_Special_Category
Neoplastic_Status
Malignant
Preferred_Name
Lung Non-Small Cell Carcinoma
Semantic_Type
Neoplastic Process
UMLS_CUI
C0007131
class Relations
Equivalent to
Subclass of
Related from
Regimen_Has_Accepted_Use_For_Disease
- Carboplatin/Nab-paclitaxel Regimen
- Atezolizumab/Carboplatin/Nab-paclitaxel Regimen
- Cisplatin/Cemiplimab/Paclitaxel Regimen
- Carboplatin/Osimertinib/Pemetrexed Regimen
- GTP Regimen
- Pembrolizumab/Pemetrexed Regimen
- Cisplatin/Paclitaxel Regimen
- MVP Regimen
- Bevacizumab/Carboplatin/Docetaxel Regimen
- Cisplatin/Gemcitabine Regimen
- Cisplatin/Nab-Paclitaxel/Pembrolizumab Regimen
- Cisplatin/Cemiplimab/Pemetrexed Regimen
- Cisplatin/Osimertinib/Pemetrexed Regimen
- Docetaxel/Ramucirumab Regimen
- Cisplatin/Paclitaxel/Pembrolizumab Regimen
- Cisplatin/Vinblastine Regimen
- Carboplatin/Cemiplimab/Pemetrexed Regimen
- Carboplatin/Pemetrexed Regimen
- Carboplatin/Gemcitabine Regimen
- Carboplatin/Paclitaxel Regimen
- Bevacizumab/Carboplatin/Pemetrexed Regimen
- Gemcitabine/Vinorelbine Regimen
- EP Regimen
- Carboplatin/Vinorelbine Regimen
- Carboplatin/Nab-Paclitaxel/Pembrolizumab Regimen
- Bevacizumab/Carboplatin/Paclitaxel Regimen
- Cisplatin/Docetaxel Regimen
- Carboplatin/Cemiplimab/Paclitaxel Regimen
- Carboplatin/Docetaxel Regimen
- Docetaxel/Vandetanib Regimen
- Bevacizumab/Cisplatin/Pemetrexed Regimen
- Cisplatin/Pembrolizumab/Pemetrexed Regimen
- Docetaxel/Gemcitabine Regimen
Gene_Associated_With_Disease
Gene_Product_Malfunction_Associated_With_Disease